IODAMIDE

Details

Stereochemistry	ACHIRAL
Molecular Formula	C12H11I3N2O4
Molecular Weight	627.9402
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CC(=O)NCC1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I

InChI

InChIKey=VVDGWALACJEJKG-UHFFFAOYSA-N

InChI=1S/C12H11I3N2O4/c1-4(18)16-3-6-8(13)7(12(20)21)10(15)11(9(6)14)17-5(2)19/h3H2,1-2H3,(H,16,18)(H,17,19)(H,20,21)

HIDE SMILES / InChI

Molecular Formula	C12H11I3N2O4
Molecular Weight	627.9402
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: http://www.drugfuture.com/mt/meglumine-iodamide.pdf

Iodamide is an ionic monomeric iodinated radiographic contrast medium. It was used in many procedures and may be given intravenously or by other routes, for example by instillation into the bladder or uterus; it has also been used for computed tomography. It is usually given as a 24 to 65% solution of the meglumine salt, or as a mixture of the sodium and meglumine salts; solutions of the sodium salt have also been used. Iodamide is no longer marketed in the US.

Originator

Approval Year

Conditions

Condition	Modality	Targets	Highest Phase	Product
Contrast agent 13 Sources: https://www.ndrugs.com/?s=renovue-65	Diagnostic		Approved 8583	RENOVUE-65 Approved Use Unknown Launch Date 1978

AUC

Value	Dose	Analyte	Population
2.58 g × h/L EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/338644	24.75 g single, intravenous dose: 24.75 g route of administration: Intravenous experiment type: SINGLE co-administered:	IODAMIDE plasma	Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN
6.69 g × h/L EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/338644	61.82 g single, intravenous dose: 61.82 g route of administration: Intravenous experiment type: SINGLE co-administered:	IODAMIDE plasma	Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN
14.02 g × h/L EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/338644	9.8 g single, intravenous dose: 9.8 g route of administration: Intravenous experiment type: SINGLE co-administered:	IODAMIDE plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN

T_1/2

Value	Dose	Analyte	Population
1.29 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/338644	24.75 g single, intravenous dose: 24.75 g route of administration: Intravenous experiment type: SINGLE co-administered:	IODAMIDE plasma	Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN
1.02 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/338644	61.82 g single, intravenous dose: 61.82 g route of administration: Intravenous experiment type: SINGLE co-administered:	IODAMIDE plasma	Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN
16.4 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/338644	9.8 g single, intravenous dose: 9.8 g route of administration: Intravenous experiment type: SINGLE co-administered:	IODAMIDE plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN

F_unbound

Value	Dose	Co-administered	Analyte	Population
95% EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/338644	24.75 g single, intravenous dose: 24.75 g route of administration: Intravenous experiment type: SINGLE co-administered:		IODAMIDE plasma	Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN
95% EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/338644	61.82 g single, intravenous dose: 61.82 g route of administration: Intravenous experiment type: SINGLE co-administered:		IODAMIDE plasma	Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: UNKNOWN

Sourcing

Vendor/Aggregator	ID	URL
ChEBI	CHEBI:31703	https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:31703
ZINC	ZINC000003830933	http://zinc15.docking.org/substances/ZINC000003830933

PubMed

Title	Date	PubMed
Diagnostic image quality of hysterosalpingography: ionic versus non ionic water soluble iodinated contrast media.	2009-07	21611058
Effects of iodinated contrast media on endothelium: An in vitro study.	2007-03	17113744
Contrast-enhanced voiding US for grading of reflux in adult patients prior to antireflux ureteral implantation.	2004-10	15317946
[The effect of diagnostic contrast media on the activity of lactate dehydrogenase in rat blood].	2002-11-27	12449078
Comparative multiclinical studies of iodamide and diatrizoate in excretory urography.	1973-01	4566357

Sample Use Guides

In Vivo Use Guide

24% or 65%

Route of Administration: Intravenous

In Vitro Use Guide

Unknown

Substance Class	Chemical Created by `admin` on `Wed Apr 02 07:55:31 GMT 2025` Edited by `admin` on `Wed Apr 02 07:55:31 GMT 2025`
Record UNII	4RII332O0R
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

IODAMIDE

Official Name

English

JODOMIRON

Preferred Name

English

SH 926

Code

English

SH-926

Code

English

IODAMIDE [USAN]

Common Name

English

iodamide [INN]

Common Name

English

IODAMIDE [MART.]

Common Name

English

.ALPHA.,5-DIACETAMIDO-2,4,6-TRIIODO-M-TOLUIC ACID

Systematic Name

English

IODAMIDE [MI]

Common Name

English

Iodamide [WHO-DD]

Common Name

English

IODAMIDE [JAN]

Common Name

English

BENZOIC ACID, 3-(ACETYLAMINO)-5-((ACETYLAMINO)METHYL)-2,4,6-TRIIODO-

Common Name

English

UROMIRO

Brand Name

English

B-4130

Code

English

UROMIRON

Brand Name

English

Classification Tree Code System Code

NCI_THESAURUS

C28500